Probiotic-Driven Therapeutic Vaccine for in Vivo Reprogramming of Tumor Cells To Elicit Postoperative Antitumor Immunity

Journal:
ACS Nano
Published:
DOI:
10.1021/acsnano.5c16193
Affiliations:
4
Authors:
8
Go to article
Institutions Authors Share
Biomedical Basic Research Center (BBRC) of Jiangsu Province, China
6.833333
 0.85
Simcere Pharmaceutical Group, China
0.500000
 0.06
Zhejiang Cancer Hospital (ZJCH), China
0.333333
 0.04
Chinese Academy of Sciences (CAS), China
0.333333
 0.04
Interested in Oncology and Carcinogenesis?